New Publication from GW Researchers Highlights Link Between Aspirin use and Decreased COVID-19 Severity in Hospitalized Patients
A recent clinical research report led by Jonathan H. Chow, Assistant Professor of Anesthesiology and Critical Care Medicine at the George Washington University, found that the use of aspirin may be associated with improved outcomes for hospitalized COVID-19 patients. The study entitled Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019 was published in the journal Anesthesia & Analgesia tracked 412 adult patients with COVID-19 and suggests that aspirin may provide lung-protective effects that help reduce the need for mechanical ventilation and ICU admissions. The article was featured in a recent news release from the American Association for the Advancement of Science. A randomized control trial is now needed to assess whether there is a causal relationship between aspirin use and a reduction in lung injury among COVID-19 patents.
Interested in learning more about COVID-19 related research at GW? Check out our COVID-19 Publications by GW Authors collection in our institutional repository Health Sciences Research Commons.
